How many café‑au‑lait macules and what size criteria indicate neurofibromatosis type 1, and what initial diagnostic work‑up is recommended?

Neurofibromatosis Type 1: Café-au-Lait Macule Diagnostic Criteria

Six or more café-au-lait macules (CALMs) measuring ≥5 mm in prepubertal children or ≥15 mm in postpubertal individuals constitute one of the major diagnostic criteria for NF1, and when present with typical morphology, predict NF1 diagnosis in the majority of cases.

Diagnostic Threshold and Size Criteria

The diagnostic threshold requires:

• ≥6 café-au-lait macules AND
• Size criteria:
  • ≥5 mm in greatest diameter (prepubertal children)
  • ≥15 mm in greatest diameter (postpubertal individuals)

This represents one of seven clinical criteria, where meeting two or more establishes the diagnosis of NF1 1.

Predictive Value of CALM Number

The number of CALMs at presentation strongly predicts eventual NF1 diagnosis:

• ≥6 typical CALMs: 77% (34/44) eventually met full NF1 diagnostic criteria 2
• Mean CALM count in confirmed NF1: 11.8 macules at presentation
• Mean CALM count in non-NF1: 4.6 macules at presentation 2

Higher CALM numbers correlate with increased likelihood of NF1 and potentially more severe disease manifestations, including higher prevalence of plexiform neurofibromas 3.

Temporal Progression in Early Childhood

CALM burden increases dramatically during the first two years of life:

• 6 months: Mean 5.86 CALMs; 38.1% meet diagnostic threshold
• 12 months: Steepest increase period
• 24 months: Mean 17.49 CALMs; 96.8% meet diagnostic threshold 4, 5

Among children initially below threshold (<6 CALMs), 94.5% met diagnostic criteria by 24 months 4. This defines a critical diagnostic window requiring longitudinal follow-up for infants presenting with isolated CALMs.

Morphologic Features

"Typical" versus "atypical" CALM appearance matters significantly:

• Only 2/42 patients with atypical CALMs met NF1 criteria
• 34/68 patients with typical CALMs met NF1 criteria 2

Typical CALMs are uniformly hyperpigmented, well-demarcated macules with smooth borders. The thoracic region is the most common anatomical location (53.6% of cases) 5.

Initial Diagnostic Work-Up

Clinical Evaluation

Perform comprehensive dermatologic examination documenting:

• Total CALM count and size measurement (use greatest diameter)
• Morphologic characteristics (typical vs. atypical appearance)
• Anatomical distribution (document with standardized photography if possible)
• Axillary and inguinal freckling (intertriginous freckling; appears in 52% of NF1 cases) 6
• Cutaneous neurofibromas (present in 64% of pediatric cases) 6

Ophthalmologic Examination

Slit-lamp examination for Lisch nodules (iris hamartomas):

• Present in 52% of pediatric NF1 cases 6
• Establishes second diagnostic criterion when combined with CALMs

Family History Assessment

Document three-generation pedigree:

• 52% of pediatric NF1 cases have positive family history 6
• Remaining cases represent de novo mutations
• Autosomal dominant inheritance with 50% recurrence risk per pregnancy 1

Genetic Testing

Molecular genetic testing for NF1 gene variants should be pursued when:

• Clinical diagnosis remains uncertain
• Prenatal/preimplantation diagnosis is desired
• Patient presents with isolated CALMs without other diagnostic features 1

Genetic testing confirms diagnosis but does not predict phenotypic severity due to extreme variability 1.

Baseline Imaging Considerations

For confirmed or suspected NF1:

• MRI of known or suspected plexiform neurofibromas (baseline documentation) 1
• No routine vascular screening is recommended in asymptomatic adults (insufficient evidence) 1

Follow-Up Strategy for Isolated CALMs

For children <24 months with ≥6 typical CALMs but no other diagnostic features:

1. Clinical re-evaluation every 6-12 months until age 24 months minimum
2. Annual ophthalmologic examination for Lisch nodules
3. Document CALM progression with photography
4. Most will meet full diagnostic criteria by age 6 years, typically within 3 years of initial evaluation 7

Children with 7-12 CALMs at 12 months warrant heightened surveillance for CNS and skeletal manifestations (significantly higher risk) 5.

Critical Pitfall

Common conditions mimicking multiple CALMs include:

• Bannayan-Riley-Ruvalcaba syndrome
• Multiple lentigines syndrome
• McCune-Albright syndrome (fibrous dysplasia)
• Isolated familial café-au-lait spots 7, 8

Atypical CALM morphology should prompt consideration of alternative diagnoses rather than presumptive NF1 diagnosis 2.

Referral Indications

Refer to specialized NF1 clinic when 1:

• ≥6 CALMs meeting size criteria are present
• Any additional NF1 diagnostic features emerge
• Genetic counseling is needed for family planning
• Multidisciplinary coordination is required (given 8-15 year reduction in life expectancy from malignancies and cardiovascular causes) 1